These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14694825)

  • 1. Attention deficit hyperactivity disorder (ADHD)--life insurance implications.
    Cotlar MJ
    J Insur Med; 2003; 35(1):51-6. PubMed ID: 14694825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of ADHD and its treatment on substance abuse in adults.
    Wilens TE
    J Clin Psychiatry; 2004; 65 Suppl 3():38-45. PubMed ID: 15046534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Biederman J; Petty CR; Dolan C; Hughes S; Mick E; Monuteaux MC; Faraone SV
    Psychol Med; 2008 Jul; 38(7):1027-36. PubMed ID: 18205967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors, clinical characteristics, and outcome of conduct disorder in girls with attention-deficit/hyperactivity disorder: a longitudinal study.
    Monuteaux MC; Faraone SV; Michelle Gross L; Biederman J
    Psychol Med; 2007 Dec; 37(12):1731-41. PubMed ID: 17451627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADHD treatment across the life cycle.
    Spencer TJ
    J Clin Psychiatry; 2004; 65 Suppl 3():22-6. PubMed ID: 15046532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR; Evans SM; Brooks DJ; Kalbag AS; Garawi F; Nunes EV
    Drug Alcohol Depend; 2006 Feb; 81(2):137-48. PubMed ID: 16102908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
    Levin FR
    J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of a special consultation for attention deficit/hyperactivity disorder in adults].
    Davids E; Krause DA; Specka M; Gastpar M
    Gesundheitswesen; 2004 Jul; 66(7):416-22. PubMed ID: 15314733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
    Kordon A; Kahl KG
    Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults.
    Asherson P
    Expert Rev Neurother; 2005 Jul; 5(4):525-39. PubMed ID: 16026236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
    Todd RD; Huang H; Henderson CA
    J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
    Wilens TE; Haight BR; Horrigan JP; Hudziak JJ; Rosenthal NE; Connor DF; Hampton KD; Richard NE; Modell JG
    Biol Psychiatry; 2005 Apr; 57(7):793-801. PubMed ID: 15820237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?
    Antshel KM; Faraone SV; Maglione K; Doyle A; Fried R; Seidman L; Biederman J
    Psychol Med; 2009 Aug; 39(8):1325-35. PubMed ID: 19105857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.
    Biederman J
    J Clin Psychiatry; 2004; 65 Suppl 3():3-7. PubMed ID: 15046528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration?
    Looby A
    Addict Behav; 2008 Mar; 33(3):451-63. PubMed ID: 18037571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
    Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.
    Babcock T; Ornstein CS
    Postgrad Med; 2009 May; 121(3):73-82. PubMed ID: 19491543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.